Concepedia

Sangdon Han

SH

Statistics

Publications

10

Citations

818

H-Index

10

Active since

2011

Affiliations

Arena Pharmaceuticals (United States)(Current)

Sangdon Han is an author at Arena Pharmaceuticals (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

2011–2022

10

Publications

10

GPR41/FFAR3 and GPR43/FFAR2 as Cosensors for Short-Chain Fatty Acids in Enteroendocrine Cells vs FFAR3 in Enteric Neurons and FFAR2 in Enteric Leukocytes

Mark K. Nøhr, Andreas Gille, Kristoffer L. Egerod et al. · Endocrinology · 2013 · 562 citations · Full text

Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor

Daniel J. Buzard, Sun Hee Kim, Luis Lopez et al. · ACS Medicinal Chemistry Letters · 2014 · 70 citations · Full text

, , +20

Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor

Ibragim Gaidarov, Todd L. Anthony, Joel Gatlin et al. · Pharmacological Research · 2018 · 53 citations

, , +7

Discovery of APD371: Identification of a Highly Potent and Selective CB<sub>2</sub>Agonist for the Treatment of Chronic Pain

Sangdon Han, Lars Thoresen, Jae‐Kyu Jung et al. · ACS Medicinal Chemistry Letters · 2017 · 40 citations · Full text

Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist

Jian Zhao, Shimiao Wang, Stacy Markison et al. · ACS Medicinal Chemistry Letters · 2022 · 23 citations · Full text

1–5 of 10